Are we close to defining a metabolomic signature of human obesity? A systematic review of metabolomics studies
- PMID: 31197497
- PMCID: PMC6565659
- DOI: 10.1007/s11306-019-1553-y
Are we close to defining a metabolomic signature of human obesity? A systematic review of metabolomics studies
Abstract
Introduction: Obesity is a disorder characterized by a disproportionate increase in body weight in relation to height, mainly due to the accumulation of fat, and is considered a pandemic of the present century by many international health institutions. It is associated with several non-communicable chronic diseases, namely, metabolic syndrome, type 2 diabetes mellitus (T2DM), cardiovascular diseases (CVD), and cancer. Metabolomics is a useful tool to evaluate changes in metabolites due to being overweight and obesity at the body fluid and cellular levels and to ascertain metabolic changes in metabolically unhealthy overweight and obese individuals (MUHO) compared to metabolically healthy individuals (MHO).
Objectives: We aimed to conduct a systematic review (SR) of human studies focused on identifying metabolomic signatures in obese individuals and obesity-related metabolic alterations, such as inflammation or oxidative stress.
Methods: We reviewed the literature to identify studies investigating the metabolomics profile of human obesity and that were published up to May 7th, 2019 in SCOPUS and PubMed through an SR. The quality of reporting was evaluated using an adapted of QUADOMICS.
Results: Thirty-three articles were included and classified according to four types of approaches. (i) studying the metabolic signature of obesity, (ii) studying the differential responses of obese and non-obese subjects to dietary challenges (iii) studies that used metabolomics to predict weight loss and aimed to assess the effects of weight loss interventions on the metabolomics profiles of overweight or obese human subjects (iv) articles that studied the effects of specific dietary patterns or dietary compounds on obesity-related metabolic alterations in humans.
Conclusion: The present SR provides state-of-the-art information about the use of metabolomics as an approach to understanding the dynamics of metabolic processes involved in human obesity and emphasizes metabolic signatures related to obesity phenotypes.
Keywords: Dietary intervention; Metabolic profiling; Metabolomics; Obesity and overweight; Weight loss.
Conflict of interest statement
All authors declared that they have no conflict of interest.
Similar articles
-
Circulating Unsaturated Fatty Acids Delineate the Metabolic Status of Obese Individuals.EBioMedicine. 2015 Sep 6;2(10):1513-22. doi: 10.1016/j.ebiom.2015.09.004. eCollection 2015 Oct. EBioMedicine. 2015. PMID: 26629547 Free PMC article.
-
Metabolomic Signature Between Metabolically Healthy Overweight/Obese and Metabolically Unhealthy Overweight/Obese: A Systematic Review.Diabetes Metab Syndr Obes. 2021 Mar 4;14:991-1010. doi: 10.2147/DMSO.S294894. eCollection 2021. Diabetes Metab Syndr Obes. 2021. PMID: 33692630 Free PMC article. Review.
-
Metabolite, Biochemical, and Dietary Intake Alterations Associated with Lifestyle Interventions in Obese and Overweight Malaysian Women.Nutrients. 2024 Oct 16;16(20):3501. doi: 10.3390/nu16203501. Nutrients. 2024. PMID: 39458496 Free PMC article.
-
The effect of weight management interventions that include a diet component on weight-related outcomes in pregnant and postpartum women: a systematic review protocol.JBI Database System Rev Implement Rep. 2015 Jan;13(1):88-98. doi: 10.11124/jbisrir-2015-1812. JBI Database System Rev Implement Rep. 2015. PMID: 26447010
-
The Human Breast Milk Metabolome in Overweight and Obese Mothers.Front Immunol. 2020 Jul 21;11:1533. doi: 10.3389/fimmu.2020.01533. eCollection 2020. Front Immunol. 2020. PMID: 32793208 Free PMC article. Review.
Cited by
-
Sex Dimorphism in the Metabolome of Metabolic Syndrome in Morbidly Obese Individuals.Metabolites. 2022 May 6;12(5):419. doi: 10.3390/metabo12050419. Metabolites. 2022. PMID: 35629923 Free PMC article.
-
Mapping Metabolite and ICD-10 Associations.Metabolites. 2020 May 14;10(5):196. doi: 10.3390/metabo10050196. Metabolites. 2020. PMID: 32423141 Free PMC article.
-
Untargeted metabolomics and transcriptomics identified glutathione metabolism disturbance and PCS and TMAO as potential biomarkers for ER stress in lung.Sci Rep. 2021 Jul 19;11(1):14680. doi: 10.1038/s41598-021-92779-8. Sci Rep. 2021. PMID: 34282162 Free PMC article.
-
Immunometabolic signatures predict risk of progression to sepsis in COVID-19.PLoS One. 2021 Aug 30;16(8):e0256784. doi: 10.1371/journal.pone.0256784. eCollection 2021. PLoS One. 2021. PMID: 34460840 Free PMC article.
-
Metabolic signatures and potential biomarkers of sarcopenia in suburb-dwelling older Chinese: based on untargeted GC-MS and LC-MS.Skelet Muscle. 2024 Mar 7;14(1):4. doi: 10.1186/s13395-024-00337-3. Skelet Muscle. 2024. PMID: 38454497 Free PMC article.
References
-
- Abarca-Gómez L, Abdeen ZA, Hamid ZA, Abu-Rmeileh NM, Acosta-Cazares B, Acuin C, et al. Worldwide trends in body-mass index, underweight, overweight, and obesity from 1975 to 2016: A pooled analysis of 2416 population-based measurement studies in 128·9 million children, adolescents and adults. The Lancet. 2017;390(10113):2627–2642. - PMC - PubMed
-
- Abu Bakar MH, Sarmidi MR, Cheng KK, Ali Khan A, Suan CL, Zaman Huri H, Yaakob H. Metabolomics—The complementary field in systems biology: A review on obesity and type 2 diabetes. Molecular BioSystems. 2015;11(7):1742–1774. - PubMed
-
- Adeva-Andany M, Souto-Adeva G, Ameneiros-Rodríguez E, Fernández-Fernández C, Donapetry-García C, Domínguez-Montero A. Insulin resistance and glycine metabolism in humans. Amino Acids. 2018;50(1):11–27. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Research Materials